Physician profile
Benjamin D Sturdy
NPI 1730495318
$2,170.89
in general payments reported to CMS, 2019-2025
16 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $609 · 2020: $94.54 · 2021: $550 · 2022: $319 · 2023: $52.97 · 2024: $295 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $386.00 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $368.26 | 2022-2025 | Infuse, Xiidra, Miebo |
| Kala Pharmaceuticals, INC. | $268.51 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $171.11 | 2022-2025 | Acuvue |
| Allergan, INC. | $165.36 | 2019-2021 | |
| Alcon Vision LLC | $157.03 | 2019-2022 | |
| Abbvie INC. | $148.49 | 2022-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Astellas Pharma US INC | $118.37 | 2024 | Izervay |
| Sight Sciences, INC. | $66.92 | 2019 | |
| Rxsight INC | $59.32 | 2021 | |
| Carl Zeiss Meditec, INC. | $47.57 | 2019 | |
| Coopervision INC. | $33.09 | 2023-2024 | Paragon Crt, Myday Contact Lens |
| Shire North American Group INC | $24.48 | 2019 | |
| Travere Therapeutics, INC. | $17.52 | 2019-2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Sturdy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.